Your browser doesn't support javascript.
loading
Akt Activation Mediates Acquired Resistance to Fibroblast Growth Factor Receptor Inhibitor BGJ398.
Datta, Jharna; Damodaran, Senthilkumar; Parks, Hannah; Ocrainiciuc, Cristina; Miya, Jharna; Yu, Lianbo; Gardner, Elijah P; Samorodnitsky, Eric; Wing, Michele R; Bhatt, Darshna; Hays, John; Reeser, Julie W; Roychowdhury, Sameek.
Afiliación
  • Datta J; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Damodaran S; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Parks H; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.
  • Ocrainiciuc C; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Miya J; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Yu L; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Gardner EP; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio.
  • Samorodnitsky E; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Wing MR; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Bhatt D; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Hays J; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Reeser JW; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Roychowdhury S; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.
Mol Cancer Ther ; 16(4): 614-624, 2017 04.
Article en En | MEDLINE | ID: mdl-28255027
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Pirimidinas / Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas c-akt / Neoplasias / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Pirimidinas / Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas c-akt / Neoplasias / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2017 Tipo del documento: Article